LP(a): Structure, Genetics, Associated Cardiovascular Risk, and Emerging Therapeutics.

Tasdighi, Erfan; Adhikari, Rishav; Almaadawy, Omar; Leucker, Thorsten M; Blaha, Michael J

Tasdighi, Erfan; Adhikari, Rishav; Almaadawy, Omar; Leucker, Thorsten M; Blaha, Michael J.

Tasdighi E; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; email: mblaha1@jhmi.edu.
Adhikari R; Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Almaadawy O; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Leucker TM; Department of Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA.
Blaha MJ; Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Annu Rev Pharmacol Toxicol ; 64: 135-157, 2024 Jan 23.

Article en En | MEDLINE | ID: mdl-37506332

Asunto(s)

Enfermedades Cardiovasculares; Humanos; LDL-Colesterol/metabolismo; LDL-Colesterol/uso terapéutico; Enfermedades Cardiovasculares/tratamiento farmacológico; Enfermedades Cardiovasculares/genética; Factores de Riesgo; Lipoproteína(a)/genética; Lipoproteína(a)/metabolismo; Lipoproteína(a)/uso terapéutico; Factores de Riesgo de Enfermedad Cardiaca

Palabras clave

antisense oligonucleotides; atherosclerosis; cardiovascular disease; clinical trial; lipoprotein(a); therapy

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google